Similar articles

• Adenovirus-mediated CTLA4-IgG gene therapy in orthotopic small intestinal transplantation in rats.

  Echizenya H, Yamashita K, Takehara M, Konishi K, Nomura M, Yanagida N, Kitagawa N, Kobayashi T, Furukawa H, Inobe M, Uede T, Todo S. Echizenya H, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):183-4. doi: 10.1016/s0041-1345(00)01967-9. Transplant Proc. 2001. PMID: 11266771 No abstract available.
• Adenoviral vectors containing the CTLA4IG-gene inhibit chronic rejection in heterotopically transplanted rat tracheas.

  Kita Y, Li XK, Ohba M, Funeshima N, Enosawa S, Nogimura H, Ohi S, Kageyama Y, Matsushita K, Ito Y, Takahashi T, Suzuki K, Suzuki S, Kazui T. Kita Y, et al. Transplant Proc. 2000 Nov;32(7):2036-7. doi: 10.1016/s0041-1345(00)01547-5. Transplant Proc. 2000. PMID: 11120055 No abstract available.
• Evidence that the adenoviral vector containing the CTLA4-Ig gene improves transgene expression and graft survival.

  Namii Y, Hayashi S, Yokoyama I, Kobayashi T, Yasutomi M, Nagasaka T, Uchida K, Hamada H, Takagi H. Namii Y, et al. Transplant Proc. 1997 May;29(3):1738-9. doi: 10.1016/s0041-1345(97)00038-9. Transplant Proc. 1997. PMID: 9142255 No abstract available.
• Review of CTLA4Ig use for allograft immunosuppression.

  Lin H, Wei RQ, Gordon D, Linsley P, Turka LA, Bolling SF. Lin H, et al. Transplant Proc. 1994 Dec;26(6):3200-1. Transplant Proc. 1994. PMID: 7998114 Review. No abstract available.
• Mechanisms of transplant tolerance induction using costimulatory blockade.

  Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M. Wekerle T, et al. Curr Opin Immunol. 2002 Oct;14(5):592-600. doi: 10.1016/s0952-7915(02)00378-3. Curr Opin Immunol. 2002. PMID: 12183158 Review.